Results 171 to 180 of about 185,884 (310)

Apolipoprotein A-I (CSL112) and Cardiovascular Outcomes in Atherosclerotic Cardiovascular Disease: A Scoping Review. [PDF]

Clin Cardiol
Habib A, Khan MSM, Aneeq A, Tahir HMT, Mehmoodi A, Malik J, Perveen A.   +6 more
europepmc   +1 more source

Oxidative Stress and Familial history of Cardiovascular Disease

, 2011
In the era of genomic medicine, the family health history is still the first and inexpensive tool within the reach of anyone to effectively assess the risk for a variety of disorders, such as cardiovascular disease and cancer.
MATTEUCCI, ELENA, GIAMPIETRO, OTTAVIO
core  

Multivariate linear regression to predict association of non‐invasive arterial stiffness with cardiovascular events

ESC Heart Failure, Volume 12, Issue 2, Page 1141-1150, April 2025.
Abstract Background Arterial stiffness is a crucial factor in determining an increase in systolic blood pressure and pulse pressure and can also predict the development of cardiovascular disease (CVD). The purpose of this study was to examine the relationship between arterial stiffness and future CVD.
Susan Darroudi, Mostafa Eslamiyeh, Amin Mansoori, Eisa Nazar, Maryam Alinezhad‐Namaghi, Reza Rezvani, Majid Ghayour‐Mobarhan, Habibollah Esmaily, Mohsen Moohebati, Gordon A. Ferns, Mark Ghamsary   +10 more
wiley   +1 more source

Traditional and Modern Predictors of Atherosclerotic Cardiovascular Disease in Patients with T2D and MASLD. [PDF]

Diagnostics (Basel)
Vulpescu Diaconu CT, Chitu MC, Salmen T, Pantea Stoian A, Guja C.   +4 more
europepmc   +1 more source

Taking Into Account Insulin Resistance With Associated Hyperinsulinemia to Counteract the Development of Acute and Chronic Cardiovascular Diseases

Chronic Diseases and Translational Medicine, EarlyView.
Serafino Fazio, Flora Affuso
wiley   +1 more source

The in‐hospital administration of sacubitril/valsartan in acute myocardial infarction: A meta‐analysis

ESC Heart Failure, Volume 12, Issue 2, Page 998-1012, April 2025.
In patients with Acute Myocardial Infarction related heart failure, the in‐hospital administration of ARNIs was associated with a reduced risk of MACEs and re‐hospitalizations for heart failure, as well as cardiac remodeling, compared to standard therapy.
Gianluca Di Pietro, Riccardo Improta, Paolo Severino, Andrea D'Amato, Lucia Ilaria Birtolo, Ovidio De Filippo, Antonio Lattanzio, Raffaele De Cristofaro, Giacchino Galardo, Fabrizio D'Ascenzo, Roberto Badagliacca, Gennaro Sardella, Maurizio Volterrani, Francesco Fedele, Carmine Dario Vizza, Massimo Mancone   +15 more
wiley   +1 more source

Managing Progressive Atherosclerotic Cardiovascular Disease in a Patient with Elevated Lipoprotein(a). [PDF]

Anatol J Cardiol
Yurtseven E, Tokgözoğlu L.
europepmc   +1 more source

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia, Blanche Schroen, Judith M.E.M. Cosemans   +2 more
wiley   +1 more source

Cost-effectiveness of inclisiran in patients with atherosclerotic cardiovascular disease from Chinese healthcare perspective. [PDF]

PLoS One
Liu M, Zhang X, Feng M, He Q, Feng Z.
europepmc   +1 more source

Atherosclerotic cardiovascular disease (ASCVD) biomarkers 5-10 years after a hypertensive disorder of pregnancy. [PDF]

Pregnancy Hypertens
Sinkey RG, McGee PL, Subramaniam A, Casey BM, Reddy UM, Rouse DJ, Tita ATN, Thorp JM, Chien EK, Saade GR, Blackwell SC, Landon MB, Eunice Kennedy Shriver National Institute of Child Health and Human Development.   +12 more
europepmc   +1 more source